MoneyShow's Best Investment Ideas For 2024: Part 3

Dilok Klaisataporn/iStock via Getty Images MoneyShow’s top contributing analysts, strategists, and newsletter editors share their investment recommendations for the year ahead. See Part 2 here. Celldex Therapeutics By John McCamant, Editor of The Medical Technology Stock Letter Celldex Therapeutics (CLDX) is one of our top picks for 2024. The recently reported 208-patient trial with the first-ever subcutaneous (SC) version of CLDX’s barzo in CSU confirmed that it is the Best-In-Class compound with the f ...